Skip to content

Preoperative 3D reconstruction combined with intraoperative fluorescence endoscopy for accurate segmental resection of early stage lung cancer

Preoperative 3D reconstruction combined with intraoperative fluorescence endoscopy for accurate segmental resection of early stage lung cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027347
Enrollment
Unknown
Registered
2019-11-09
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

Interventions

new precise segmental resection group:Three dimensional reconstruction combined with intraoperative fluorescence imaging for precise segmental resection
Traditional segmental resection group:Traditional segmental resection

Sponsors

Shanghai Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) the age is 18-75 years old. (2) tumor diameter 50%, or tumor doubling time > 400 days,; (3) no neoadjuvant therapy, such as chemotherapy, radiotherapy and traditional Chinese medicine treatment before operation; (4) preoperative examination and evaluation should be carried out according to NCCN guidelines to make sure that patients' cardiopulmonary function can tolerate the operation and exclude distant metastasis and serious basic diseases; (5) general status score: PS score < 3.

Exclusion criteria

Exclusion criteria: (1) preoperative CT examination did not meet the inclusion criteria (if there were distant metastasis and lymph node metastasis); (2) the preoperative examination found that the cardiopulmonary function could not tolerate the operation or there were serious basic diseases, such as serious hypertension, diabetes, neurological and mental system diseases, which could not be operated; (3) those who lost the interview or voluntarily quit the study; (4) the patient was forced to switch to thoracotomy due to uncontrollable bleeding, adhesions or other accidents during the operation.

Design outcomes

Primary

MeasureTime frame
Perioperative situation;

Secondary

MeasureTime frame
The degree of residual pulmonary expansion on CT and pulmonary function at 3 months after operation;3-year Disease Free Survival;3-year Overall Survival;5-year Disease Free Survival;5-year Overall Survival;

Countries

China

Contacts

Public ContactYao Feng

Shanghai Chest Hospital

yaofeng6796678@126.com+86 13636354837

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026